Evidence map›Paper›PMID 24287074›Full record

ReviewFrontiers in neuroendocrinology2014

Sex differences in circadian timing systems: implications for disease.

Matthew Bailey, Rae Silver

Open access · greenAbstract readReview
In one paragraph

Review in Frontiers in neuroendocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 187 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
187citing papers in PubMed, 2 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

187 citing papers in PubMed, 2 syntheses or guidelines pooled it, 340 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

127 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Matthew BaileyDepartment of Psychology, Columbia University, United States. Electronic address: mrb2225@columbia.edu.
Rae SilverDepartment of Psychology, Columbia University, United States; Department of Psychology, Barnard College, United States; Department of Pathology and Cell Biology, Columbia University Medical Center, United States. Electronic address: QR@columbia.edu.
Barnard College · USColumbia University · US

Funding

PHYSIOLOGICAL DISSECTION OF THE SCNR01NS037919 · NINDS · BARNARD COLLEGE · PI SILVER, RAE · 1998 to 2010
$3.3M
suprachiasmatic nucleus (SCN) networks and efferent signalsR01MH075045 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SILVER, RAE · 2007 to 2011
$1.8M
NIMH NIH HHS MH 075045NIMH NIH HHS R01 MH075045NINDS NIH HHS NS37919NINDS NIH HHS R01 NS037919
6 · The paper itself

Abstract

Virtually every eukaryotic cell has an endogenous circadian clock and a biological sex. These cell-based clocks have been conceptualized as oscillators whose phase can be reset by internal signals such as hormones, and external cues such as light. The present review highlights the inter-relationship between circadian clocks and sex differences. In mammals, the suprachiasmatic nucleus (SCN) serves as a master clock synchronizing the phase of clocks throughout the body. Gonadal steroid receptors are expressed in almost every site that receives direct SCN input. Here we review sex differences in the circadian timing system in the hypothalamic-pituitary-gonadal axis (HPG), the hypothalamic-adrenal-pituitary (HPA) axis, and sleep-arousal systems. We also point to ways in which disruption of circadian rhythms within these systems differs in the sexes and is associated with dysfunction and disease. Understanding sex differentiated circadian timing systems can lead to improved treatment strategies for these conditions.

Indexed as

Sex CharacteristicsAnimalsCircadian RhythmHumansHypothalamo-Hypophyseal SystemSleepSuprachiasmatic Nucleus17β-estradiol5-fluorouracil5-FU5-HTACTHaction potentialadrenocorticotropic hormoneAMYamygdalaandrogen receptorsANSanterior paraventricular thalamic nucleianterolateral paraventricular nucleusAPARARCarcuate nucleusarginine vasopressinautonomic nervous systemAVPAVPVbed nucleus of the stria terminalisBMAL1BNSTbrain and muscle ARNT-like protein1c-fosC-FOSCircadianconstant darknesscorticotropin releasing hormoneCRHDDDelayed Sleep Phase Syndromedenoting the gene or mRNAdenoting the proteinDHTdihydrotestosteroneDMHdorsal raphedorsomedial hypothalamusDRDSPSE(2)EEGelectroencephalographyEPERERαestradiol plus progesteroneestrogen receptor alphaestrogen receptorsFamilial Advanced Sleep Phase SyndromeFASPSgastrin-releasing peptideGCGDXgeniculo-hypothalamic tractGHTglucocortocoid receptorglucocortocoidsGnIHGnRHgonadectomygonadotropin inhibiting hormonegonadotropin releasing hormoneGRGRPHAhabenulaHBhistamineHormonesHPAHPGhypothalamic–adrenalhypothalamic–pituitary–gonadalIGLIMLintergeniculate leafletintermediolateral columnKiss1Kiss1 RKiss1 receptorkisspeptinknock outKOlateral hypothalamic arealateral septumLCLDLHLHAlight-darklocus coeruleusLSluteinizing hormonemedial parvocellular PVNmedial preoptic areamedial raphemedian preoptic areaMnPOmPOAmpPVNMRMUAmulti-unit neural activityNANeuronal PAS domain-containing protein 2norandrenergicNpas2ovariectomizedOVXPparaventricular nucleus of the hypothalamusPer1PER1Per2PER2Period1 gene or mRNAPeriod1 proteinPeriod2 gene or mRNAPeriod2 proteinPOApreoptic areaprogesteronePVAPVNRchReproductionretinohypothalamic tractretrochiasmatic areaRHTSCNSDserotonergicSex differencesSleepsleep deprivationsPVZStresssub paraventricular zone SWA, slow wave activitysuprachiasmatic nucleiSuprachiasmatic nucleusTtestosteroneTHTMNtuberomammillary nucleustyrosine hydroxylasevariable nucleotide tandem repeatvasoactive intestinal polypeptideventrolateral preoptic areaventromedial nucleus of the hypothalamusVIPVLPOVMHVNTRwild typeWT

Identifiers

PMID24287074
PMCPMC4041593
OpenAlexW2089689504

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.